利妥昔单抗对难治性费尔蒂综合征的有益反应。 - Suppr

Suppr

超能文献

Beneficial response to rituximab in refractory Felty Syndrome.

作者信息

Weinreb Nicole, Rabinowitz Arthur, Dellaripa Paul F

出版信息

J Clin Rheumatol. 2006 Feb;12(1):48. doi: 10.1097/01.rhu.0000200326.17729.76.

DOI:10.1097/01.rhu.0000200326.17729.76

PMID:16484886

Abstract

摘要

相似文献

Beneficial response to rituximab in refractory Felty Syndrome.

J Clin Rheumatol. 2006 Feb;12(1):48. doi: 10.1097/01.rhu.0000200326.17729.76.

Beneficial response to rituximab in a patient with haemolysis and refractory Felty syndrome.

Ann Rheum Dis. 2008 Jun;67(6):894-5. doi: 10.1136/ard.2007.077966.

Efficacy of rituximab in Felty's syndrome.

Ann Rheum Dis. 2008 Sep;67(9):1352. doi: 10.1136/ard.2007.078915.

[Case of Felty's syndrome].

Wiad Lek. 1974 Oct 15;27(20):1797-9.

Rituximab is useful in the treatment of Felty's syndrome.

Am J Ther. 2008 Jul-Aug;15(4):321-2. doi: 10.1097/MJT.0b013e318164bf32.

Lack of efficacy of rituximab in Felty's syndrome.

Ann Rheum Dis. 2005 Feb;64(2):332-3. doi: 10.1136/ard.2004.025643.

[Progress on diagnosis of Felty's syndrome].

Nihon Naika Gakkai Zasshi. 1991 Nov 10;80(11):1742-5.

Pseudo-felty's syndrome. Report of a case with no symptoms for at least 15 years.

Rev Rhum Engl Ed. 1996 Jan;63(1):56-8.

Felty's syndrome.

Minn Med. 1987 Jul;70(7):411, 413.

[Felty's syndrome].

Tidsskr Nor Laegeforen. 2000 Mar 30;120(9):1038-40.

引用本文的文献

Felty's syndrome.

Front Med (Lausanne). 2023 Oct 17;10:1238405. doi: 10.3389/fmed.2023.1238405. eCollection 2023.

Biological treatment in Felty's syndrome with profound neutropenia.

Reumatologia. 2023;61(3):213-218. doi: 10.5114/reum/167472. Epub 2023 Jul 2.

Kinetics of Rituximab Excretion into Urine and Peritoneal Fluid in Two Patients with Nephrotic Syndrome.

Case Rep Nephrol. 2017;2017:1372859. doi: 10.1155/2017/1372859. Epub 2017 Jan 24.

Targeted Therapy with Rituximab in Felty's Syndrome: A Case Report.

Open Rheumatol J. 2012;6:312-4. doi: 10.2174/1874312901206010312. Epub 2012 Nov 16.

The spectrum of large granular lymphocyte leukemia and Felty's syndrome.

Curr Opin Hematol. 2011 Jul;18(4):254-9. doi: 10.1097/MOH.0b013e32834760fb.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Beneficial response to rituximab in refractory Felty Syndrome.

J Clin Rheumatol. 2006 Feb;12(1):48. doi: 10.1097/01.rhu.0000200326.17729.76.

Beneficial response to rituximab in a patient with haemolysis and refractory Felty syndrome.

Ann Rheum Dis. 2008 Jun;67(6):894-5. doi: 10.1136/ard.2007.077966.

Efficacy of rituximab in Felty's syndrome.

Ann Rheum Dis. 2008 Sep;67(9):1352. doi: 10.1136/ard.2007.078915.

[Case of Felty's syndrome].

Wiad Lek. 1974 Oct 15;27(20):1797-9.

Rituximab is useful in the treatment of Felty's syndrome.

Am J Ther. 2008 Jul-Aug;15(4):321-2. doi: 10.1097/MJT.0b013e318164bf32.

Lack of efficacy of rituximab in Felty's syndrome.

Ann Rheum Dis. 2005 Feb;64(2):332-3. doi: 10.1136/ard.2004.025643.

[Progress on diagnosis of Felty's syndrome].

Nihon Naika Gakkai Zasshi. 1991 Nov 10;80(11):1742-5.

Pseudo-felty's syndrome. Report of a case with no symptoms for at least 15 years.

Rev Rhum Engl Ed. 1996 Jan;63(1):56-8.

Felty's syndrome.

Minn Med. 1987 Jul;70(7):411, 413.

[Felty's syndrome].

Tidsskr Nor Laegeforen. 2000 Mar 30;120(9):1038-40.

引用本文的文献

Felty's syndrome.

Front Med (Lausanne). 2023 Oct 17;10:1238405. doi: 10.3389/fmed.2023.1238405. eCollection 2023.

Biological treatment in Felty's syndrome with profound neutropenia.

Reumatologia. 2023;61(3):213-218. doi: 10.5114/reum/167472. Epub 2023 Jul 2.

Kinetics of Rituximab Excretion into Urine and Peritoneal Fluid in Two Patients with Nephrotic Syndrome.

Case Rep Nephrol. 2017;2017:1372859. doi: 10.1155/2017/1372859. Epub 2017 Jan 24.

Targeted Therapy with Rituximab in Felty's Syndrome: A Case Report.

Open Rheumatol J. 2012;6:312-4. doi: 10.2174/1874312901206010312. Epub 2012 Nov 16.

The spectrum of large granular lymphocyte leukemia and Felty's syndrome.

Curr Opin Hematol. 2011 Jul;18(4):254-9. doi: 10.1097/MOH.0b013e32834760fb.